Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas - PubMed (original) (raw)
. 2015 Mar 28;358(2):220-231.
doi: 10.1016/j.canlet.2014.12.044. Epub 2014 Dec 24.
Elizandra Braganhol 2, Karina Klafke 3, Fabrício Figueiró 3, Sílvia Resende Terra 3, Francis Jackson Paludo 3, Maurílio Morrone 3, Ivi Juliana Bristot 3, Ana Maria Battastini 3, Cassiano Mateus Forcelini 4, Alexander James Roy Bishop 5, Daniel Pens Gelain 3, José Cláudio Fonseca Moreira 3
Affiliations
- PMID: 25542083
- DOI: 10.1016/j.canlet.2014.12.044
Free article
Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas
Alfeu Zanotto-Filho et al. Cancer Lett. 2015.
Free article
Abstract
Glioblastoma is a devastating primary brain tumor resistant to conventional therapies. In this study, we tested the efficacy of combining temozolomide with curcumin, a phytochemical known to inhibit glioblastoma growth, and investigated the mechanisms involved. The data showed that synergy between curcumin and temozolomide was not achieved due to redundant mechanisms that lead to activating protective autophagy both in vitro and in vivo. Autophagy preceded apoptosis, and blocking this response with autophagy inhibitors (3-methyl-adenine, ATG7 siRNA and chloroquine) rendered cells susceptible to temozolomide and curcumin alone or combinations by increasing apoptosis. While curcumin inhibited STAT3, NFκB and PI3K/Akt to affect survival, temozolomide-induced autophagy relied on the DNA damage response and repair components ATM and MSH6, as well as p38 and JNK1/2. However, the most interesting observation was that both temozolomide and curcumin required ERK1/2 to induce autophagy. Blocking this ERK1/2-mediated temozolomide and curcumin induced autophagy with resveratrol, a blood-brain barrier permeable drug, improved temozolomide/curcumin efficacy in brain-implanted tumors. Overall, the data presented demonstrate that autophagy impairs the efficacy of temozolomide/curcumin, and inhibiting this phenomenon could provide novel opportunities to improve brain tumor treatment.
Keywords: Apoptosis; Autophagy; Curcumin; ERK1/2; Temozolomide.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Similar articles
- Targeting autophagy to sensitive glioma to temozolomide treatment.
Yan Y, Xu Z, Dai S, Qian L, Sun L, Gong Z. Yan Y, et al. J Exp Clin Cancer Res. 2016 Feb 2;35:23. doi: 10.1186/s13046-016-0303-5. J Exp Clin Cancer Res. 2016. PMID: 26830677 Free PMC article. Review. - The Synergistic Combination of Curcumin and Polydatin Improves Temozolomide Efficacy on Glioblastoma Cells.
Serafino A, Krasnowska EK, Romanò S, De Gregorio A, Colone M, Dupuis ML, Bonucci M, Ravagnan G, Stringaro A, Fuggetta MP. Serafino A, et al. Int J Mol Sci. 2024 Sep 30;25(19):10572. doi: 10.3390/ijms251910572. Int J Mol Sci. 2024. PMID: 39408901 Free PMC article. - Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy.
Golden EB, Cho HY, Jahanian A, Hofman FM, Louie SG, Schönthal AH, Chen TC. Golden EB, et al. Neurosurg Focus. 2014 Dec;37(6):E12. doi: 10.3171/2014.9.FOCUS14504. Neurosurg Focus. 2014. PMID: 25434381 - Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma.
Wu H, Liu Q, Cai T, Chen YD, Wang ZF. Wu H, et al. Mol Med Rep. 2015 Oct;12(4):5461-6. doi: 10.3892/mmr.2015.4087. Epub 2015 Jul 17. Mol Med Rep. 2015. PMID: 26239619 - Autophagy, the Trojan horse to combat glioblastomas.
Lefranc F, Kiss R. Lefranc F, et al. Neurosurg Focus. 2006 Apr 15;20(4):E7. doi: 10.3171/foc.2006.20.4.4. Neurosurg Focus. 2006. PMID: 16709038 Review.
Cited by
- Demethoxycurcumin analogue DMC-BH inhibits orthotopic growth of glioma stem cells by targeting JNK/ERK signaling.
Shi L, Sun G, Zhu H. Shi L, et al. Aging (Albany NY). 2020 Jul 24;12(14):14718-14735. doi: 10.18632/aging.103531. Epub 2020 Jul 24. Aging (Albany NY). 2020. PMID: 32710727 Free PMC article. - Action of Curcumin on Glioblastoma Growth: A Systematic Review with Meta-Analysis of Animal Model Studies.
Luís Â, Amaral L, Domingues F, Pereira L, Cascalheira JF. Luís Â, et al. Biomedicines. 2024 Jan 24;12(2):268. doi: 10.3390/biomedicines12020268. Biomedicines. 2024. PMID: 38397870 Free PMC article. Review. - Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents.
Verbaanderd C, Maes H, Schaaf MB, Sukhatme VP, Pantziarka P, Sukhatme V, Agostinis P, Bouche G. Verbaanderd C, et al. Ecancermedicalscience. 2017 Nov 23;11:781. doi: 10.3332/ecancer.2017.781. eCollection 2017. Ecancermedicalscience. 2017. PMID: 29225688 Free PMC article. - Targeting autophagy to sensitive glioma to temozolomide treatment.
Yan Y, Xu Z, Dai S, Qian L, Sun L, Gong Z. Yan Y, et al. J Exp Clin Cancer Res. 2016 Feb 2;35:23. doi: 10.1186/s13046-016-0303-5. J Exp Clin Cancer Res. 2016. PMID: 26830677 Free PMC article. Review. - miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
Li H, Chen L, Li JJ, Zhou Q, Huang A, Liu WW, Wang K, Gao L, Qi ST, Lu YT. Li H, et al. J Hematol Oncol. 2018 May 29;11(1):70. doi: 10.1186/s13045-018-0618-0. J Hematol Oncol. 2018. PMID: 29843746 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous